COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,306 Articles (22,772 medRxiv, 8,534 bioRxiv)

Most recent first Previous |  Page 1924: Articles 19231-19240  | Next

Prevalence of RT-PCR-detected SARS-CoV-2 infection at schools: First results from the Austrian School-SARS-CoV-2 Study
Willeit, P., Krause, R., Lamprecht, B., Berghold, A., Hanson, B., Stelzl, E., Stoiber, H., Zuber, J., Heinen, R., Koehler, A., Bernhard, D., Borena, W., Doppler, C., von Laer, D., Schmidt, H., Proell, J., Steinmetz, I., Wagner, M.
10.1101/2021.01.05.20248952 — Posted: 2021-01-06 Discussion: Onsite
Representative Estimates of COVID-19 Infection Fatality Rates from Three Locations in India
Cai, R., Novosad, P., Tandel, V., Asher, S., Malani, A.
10.1101/2021.01.05.21249264 — Posted: 2021-01-06
Stochastic model for COVID-19 in slums: interaction between biology and public policies
Solari, H. G., Natiello, M. A.
10.1101/2021.01.06.21249318 — Posted: 2021-01-06
A novel computational approach to reconstruct SARS-CoV-2 infection dynamics through the inference of unsampled sources of infection
Perera, D., Perks, B., Potemkin, M., Gordon, P., Gill, J., van Marle, G., Long, Q.
10.1101/2021.01.04.21249233 — Posted: 2021-01-06 Discussion: Onsite
Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials
H. Talasaz, A., Sadeghipour, P., Kakavand, H., Aghakouchakzadeh, M., Van Tassell, B. W., Kordzadeh-Kermani, E., Gheymati, A., Ariannrjad, H., Hosseini, S. H., Jamalkhani, S., Sholzberg, M., Monreal, M., Jimenez, D., Piazza, G., Parikh, S. A., Kirtane, A. J., Eikelboom, J. W., Connors, J. M., Hunt, B. J., Konstantinides, S. V., Cushman, M., Weitz, J. I., Stone, G., Krumholz, H., Lip, G. Y. H., Goldhaber, S. Z., Bikdeli, B.
10.1101/2021.01.04.21249227 — Posted: 2021-01-06
Modelling COVID -19 Transmission in a Hemodialysis Centre Using Simulation Generated Contacts Matrices
Tofighi, M., Asgary, A., Merchant, A. A., Shafiee, M. A., M. Najafabadi, M., Nadri, N., Aarabi, M., Heffernan, J., Wu, J.
10.1101/2021.01.03.21249175 — Posted: 2021-01-06 Discussion: Onsite
Outbreak or pseudo-outbreak? Integrating SARS-CoV-2 sequencing to validate infection control practices in an end stage renal disease facility
Pfaff, B. L., Richmond, C. S., Sabin, A. P., Athas, D. M., Adams, J. C., Meller, M. E., Usha, K., Schmitz, S. A., Simmons, B. J., Borgert, A. J., Kenny, P. A.
10.1101/2020.12.30.20249062 — Posted: 2021-01-06
State-level COVID-19 Trend Forecasting Using Mobility and Policy Data
Wang, Y., Peng, H., Sha, L., Liu, Z., Hong, P.
10.1101/2021.01.04.21249218 — Posted: 2021-01-06
Modeling COVID-19 outbreaks in United States with distinct testing, lockdown speed and fatigue rates
Gulbudak, H., Browne, C., Macdonald, J. C.
10.1101/2021.01.04.21249231 — Posted: 2021-01-06
Reverse Transcriptase Loop Mediated Isothermal Amplification (RT-LAMP) for COVID-19 Diagnosis: A Systematic Review and Meta-Analysis
Subali, A. D., Wiyono, L.
10.1101/2021.01.04.20248979 — Posted: 2021-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).